120 likes | 132 Views
<br>Read here the latest updates on the Digital breast tomosynthesis equipment market published by CMI team.<br>
E N D
Coherent Marketing Insights https://www.coherentmarketinsights.com/ Market Research & Business Consulting Services Covid-19 Impact Tracker
DIGITAL BREAST TOMOSYNTHESIS EQUIPMENT MARKET ANALYSIS Digital Breast Tomosynthesis Equipment Market, By Product Type (Equipment, Upgradation), By End User (Hospitals, Diagnostic Centres), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Global Digital Breast Tomosynthesis (DBT) Equipment Market: Drivers Increasing incidence of breast cancer is a major factor boosting growth of the global digital breast tomosynthesis (DBT) equipment market over the forecast period. For instance, according to Breastcancer.org, in 2019, an estimated 268,600 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S. along with 62,930 new cases of non-invasive (in situ) breast cancer. Increasing awareness about early diagnosis of breast cancer is also expected to aid in growth of the market. Screening with DBT results in improved breast cancer detection rates and fewer call-backs – instances where women are called back from screening for additional testing because of a potentially abnormal finding. North America region held dominant position in the global digital breast tomosynthesis (DBT) equipment market in 2019, accounting for 55.1% share in terms of value, followed by Europe.
Figure 1. Global Digital Breast Tomosynthesis (DBT) Equipment Market Share (%), by Region, 2019
Global Digital Breast Tomosynthesis (DBT) Equipment Market: Restraints Lack of evidence regarding efficacy of DBT is expected to hinder growth of the global digital breast tomosynthesis (DBT) equipment market. Significant trials of DBT have not been performed. These trials require a large participant pool to demonstrate a substantial benefit in cancer detection of DBT. Moreover, increased radiologist interpretation time is also expected to hamper growth of the market. DBT image sets reading requires almost the double the time required for interpretation of 2D mammograms due to the bulk of images produced; approx. 200 images compared to four for 2D view.
Global Digital Breast Tomosynthesis (DBT) Equipment Market: Opportunities During DBT, patients are exposed to higher levels of radiation than with 2D mammography. Therefore, decreasing the radiation exposure is expected to offer lucrative growth opportunities for players in the global digital breast tomosynthesis (DBT) equipment market. Regulatory bodies also need to define the use of DBT in breast cancer-screening (individual and organized) and its role in the diagnosis and staging of breast cancer (multiple lesions) Hospitals segment in the global digital breast tomosynthesis (DBT) equipment market was valued at US$ 968.6 Mn in 2019 and is expected to reach US$ 2,866.8 Mn by 2027 at a CAGR of 14.5% during the forecast period.
Market Trends/Key Takeaways Major players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in January 2020, Planmed Oy, a Finland-based medical technology company, collaborated with IBEX Innovations Ltd., the UK-based medical X-ray software solutions provider, to integrate the IBEX Trueview gridless scatter correction software with the Planmed Clarity digital mammography systems. R&D in DBT is expected to aid in growth of the market. For instance, in January 2018, researchers from Northeastern University reportedly presented the first near-field radar imaging experimental system that can be used in a co-registered fashion with the DBT machine at the Massachusetts General Hospital. Global Digital Breast Tomosynthesis (DBT) Equipment Market: Competitive Landscape Major players operating in the global digital breast tomosynthesis (DBT) equipment market include, Hologic, Inc., Internazionale Medico Scientifica S.r.l, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, and Planmed OY.
Global Digital Breast Tomosynthesis (DBT) Equipment Market: Key Developments Major players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in November 2018, Planmed Oy collaborated with Disior Oy for integrating Disior’s orthopedic analysis software with Planmed’s high-tech Cone Beam Computed Tomography (CBCT) scanner, Planmed Verity. Major players in the market are also focused on product launch to expand their product portfolio. For instance, in December 2019, FUJIFILM Medical Systems U.S.A., Inc., a part of the Fujifilm Healthcare portfolio, added three new digital x-ray suites – FDR Clinica U, FDR Clinica X and D-EVO Suite FSx – to its portfolio of imaging technologies at the 105th annual meeting of the Radiological Society of North America (RSNA).
Request Sample Report Request Customization Download PDF Brochure Talk to Analyst Referance: https://www.coherentmarketinsights.com/market-insight/digital-breast-tomosynthesis-equipment-market-3445
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. What We Provide:Customized Market Research AnalysisIndustry Analysis ServicesBusiness Consulting ServicesLong Term Engagement ModelCountry Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt. LTD.Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You Kindly Follow CMI Social Media Profiles for the latest Company Updates. Facebook Linkedin Twitter https://www.coherentmarketinsights.com/